Alternatives to Myrbetriq If You Can't Fill Your Prescription

Myrbetriq (mirabegron) has earned a reputation as one of the better-tolerated overactive bladder (OAB) medications — but what happens when your pharmacy is out, your insurance won't cover it, or the cost is simply too high? The good news is that you have real options. This article breaks down the main alternatives to Myrbetriq so you can have an informed conversation with your doctor.

Why People Look for Myrbetriq Alternatives

Patients seek alternatives to Myrbetriq for several common reasons:

• Pharmacy stock is out or supply is inconsistent due to generic patent issues
• Insurance requires step therapy — trying other drugs before covering mirabegron
• Brand-name cost is too high ($457+ per 30 tablets without insurance)
• Blood pressure concerns — Myrbetriq can raise blood pressure in some patients
• Insufficient symptom control even at the maximum 50 mg dose

Alternative 1: Vibegron (Gemtesa) — Same Class as Myrbetriq

Vibegron (brand name Gemtesa) is the most pharmacologically similar alternative to Myrbetriq. It's also a beta-3 adrenergic agonist — the same class — working by relaxing the bladder muscle during filling. Taken as one 75 mg tablet once daily, it offers similar efficacy to mirabegron with a comparable side effect profile. The main downside: Gemtesa is brand-name only with a retail price similar to Myrbetriq (around $692 for 30 tablets). However, if your insurance covers one but not the other, or if one is more readily available at your pharmacy, switching within the class is an option worth discussing with your doctor.

Alternative 2: Oxybutynin — The Inexpensive Anticholinergic

Oxybutynin is one of the oldest and cheapest OAB medications available. Generic oxybutynin immediate-release can cost as little as $5-10 per month, making it dramatically more affordable than Myrbetriq. It's widely stocked at virtually every pharmacy. The tradeoff is side effects: oxybutynin is an anticholinergic, meaning it commonly causes dry mouth, constipation, blurred vision, and drowsiness. In older adults especially, anticholinergics are associated with cognitive concerns with long-term use. Still, for many patients — especially younger, healthier patients on short-term use — oxybutynin provides effective OAB symptom control.

Oxybutynin comes in several forms: immediate-release (IR) tablets, extended-release (ER) tablets, a transdermal patch, and a topical gel. The ER and transdermal forms tend to have fewer side effects than the IR tablets.

Alternative 3: Solifenacin (Vesicare) — Often Paired With Myrbetriq

Solifenacin (Vesicare) is an antimuscarinic that is FDA-approved in combination with Myrbetriq for patients who need more OAB control than either drug provides alone. As a standalone alternative, solifenacin (now available generically) is more bladder-selective than oxybutynin and tends to have fewer systemic side effects. Common side effects include dry mouth and constipation. There's also a potential risk of QT prolongation (an effect on heart rhythm) that's worth discussing with your doctor. Generic solifenacin is significantly less expensive than brand Vesicare.

Alternative 4: Tolterodine (Detrol) — A Well-Tolerated Anticholinergic

Tolterodine (brand: Detrol) is another antimuscarinic OAB medication available in immediate-release and extended-release (LA) formulations. Generic tolterodine is widely available and affordable. Studies show it has similar efficacy to oxybutynin with a somewhat better tolerability profile — patients tend to stick with tolterodine longer than oxybutynin. It doesn't carry the same risk of elevated blood pressure as Myrbetriq, which makes it a good option for patients with existing hypertension who need to switch.

Alternative 5: Fesoterodine (Toviaz) and Darifenacin (Enablex)

Fesoterodine (Toviaz) and darifenacin (Enablex) are two other FDA-approved antimuscarinics for OAB. Both are available as extended-release tablets. Darifenacin is more bladder-selective and may cause less dry mouth than some alternatives. Fesoterodine is a prodrug of the active tolterodine metabolite and is available in 4 mg and 8 mg strengths. Generics are available for both.

Alternative 6: Onabotulinumtoxin A (Botox) for Refractory OAB

For patients whose OAB is not controlled by oral medications, onabotulinumtoxin A (Botox) injected directly into the bladder muscle is an FDA-approved option. Administered in a urologist's office, Botox injections can significantly reduce urgency and frequency for 6-12 months per treatment. It requires cystoscopy (a scope procedure) and carries a risk of urinary retention. For patients with access to a urologist and refractory OAB, this is a meaningful alternative.

How to Choose the Right Alternative

The best alternative depends on several factors: your age, blood pressure, other medications, insurance coverage, and cost tolerance. Key considerations:

• Older adults (65+): Avoid or use caution with strong anticholinergics (oxybutynin IR) due to cognitive side effect risk; Myrbetriq or Gemtesa are generally preferred
• Hypertension: Avoid Myrbetriq or monitor blood pressure closely; tolterodine or solifenacin may be better options
• Cost-driven switch: Generic oxybutynin (as low as $5-10/month), generic tolterodine, or generic solifenacin are all budget-friendly alternatives
• Insurance step therapy: Your plan may actually require you to try oxybutynin or tolterodine first before approving Myrbetriq coverage

Still Want Myrbetriq? Here's How to Find It

If you prefer to stick with Myrbetriq, medfinder can help you find which pharmacies near you currently have it in stock. See our full guide: How to Find Myrbetriq in Stock Near You.